Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Solid Phase Peptide Synthesis (SPPS) . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109748950B reveals a novel Pd-catalyzed solid-phase method for Selepressin, offering high purity and simplified purification for reliable pharmaceutical intermediate supply chains.
Patent CN102241746B details a high-purity solid-phase synthesis for Enfuvirtide, offering significant cost reductions and scalable production capabilities for pharmaceutical manufacturers.
Patent CN112912390A reveals a convergent solid-phase method for Liraglutide and Semaglutide using pseudoproline fragments to ensure high yield and purity for pharmaceutical manufacturing.
Patent CN111233714B discloses a symmetric linker improving MAPS vaccine antigen synthesis yield and purity significantly for reliable pharmaceutical intermediate supply.
Novel synthetic route for Teriparatide Impurity F achieving 92% purity. Optimized solid-phase peptide synthesis for reliable pharmaceutical intermediate supply and cost reduction.
Novel solid-phase synthesis method for Samoamide A ensures high purity and yield, offering cost reduction in peptide manufacturing and reliable supply chain solutions.
Patent CN112062829A reveals a hybrid solid-liquid phase synthesis for Elcatonin. Achieve >98% purity and reduced waste for reliable API intermediate manufacturing.
Novel solid-phase method for Plecanatide (CN113444150A) achieves >99% purity and 60%+ yield. Reliable pharmaceutical intermediate supplier offering cost-effective scale-up solutions.
Novel solid-phase synthesis for peptide derivatives ensures high optical purity and yield, offering cost-effective manufacturing solutions for pharmaceutical intermediates.
Patent CN109456404B reveals pseudo-proline dipeptide strategy enhancing purity and scalability for global pharmaceutical supply chains.
Advanced soluble fragment strategy for Palmitoyl tetrapeptide-7 production. Overcomes purification bottlenecks and ensures high-purity supply for cosmetic manufacturing.
Patent CN111479800B reveals solid-phase synthesis for kappa opioid agonists. Offers high purity and scalable production for reliable pharmaceutical intermediate supply chains.
Patent CN113135991A reveals a fragment condensation method reducing D-His impurities. Enhances purity and yield for scalable GLP-1 manufacturing.
Novel thalidomide-based PROTACs for fibrosis and cancer. Efficient solid-phase synthesis ensures high purity and scalable supply chain solutions.
Patent CN101838308A reveals a streamlined solid-phase route for Eptifibatide using single-protected amino acids and rapid hydrogen peroxide oxidation, offering significant cost and supply chain advantages for pharmaceutical manufacturers.
Novel solid-phase method enhances purity and yield. Reliable supply chain for complex peptide intermediates with optimized cyclization.
Advanced Fmoc solid-phase synthesis for Triptorelin bulk drug. Patent CN103012565A offers high yield, low racemization, and scalable manufacturing for reliable supply chains.
Patent CN102190709A details a novel two-fragment solid-phase synthesis for LH-RH derivatives, offering high purity and cost-effective manufacturing solutions.
Patent CN103087177A details microwave-assisted solid-phase synthesis of stable GLP-1 analogues with extended half-life, offering cost-effective manufacturing solutions.
Novel solid-phase synthesis of Teixobactin analogs via copper-mediated cyclization. Reduces steps and cost for antibiotic manufacturing.